TY - CHAP M1 - Book, Section TI - Hypercoagulable States Associated with Malignancy A1 - Michaelis, Laura C. A2 - Dieter, Robert S. A2 - Dieter, Raymond A. A2 - Dieter, Raymond A. PY - 2011 T2 - Venous and Lymphatic Diseases AB - Malignancy, whether in the form of a solid tumor or hematologic neoplasm, constitutes a significant risk for hypercoagulability. Venous and arterial thromboembolic diseases are important causes of death and morbidity in individuals with cancer.1,2,3,4 It is estimated that venous clots complicate the clinical course of about 20% of all patients diagnosed with or treated for a malignancy,5,6 and even that figure may underestimate the problem, given autopsy findings of thrombosis in as many as 50% of patients with cancer.7 SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - accesscardiology.mhmedical.com/content.aspx?aid=1126489466 ER -